Seeing Is Believing
Healthcare - Sector
Coherus BioSciences's activity chart (see below) currently has 132 price targets and 115 ratings on display.
Analysts average stock forecasts to be materialized ratio is 11.93% with an average time for these price targets to be met of 59.09 days.
Most recent stock forecast was given by from MAXIM GROUP on 04-Sep-2025. First documented stock forecast 20-Jan-2016.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 04-Sep-2025
$4
$2.5 (166.67%)
1 years 1 months 1 days ago
(04-Sep-2025)
3/10 (30%)
$2.69 (205.34%)
181
Buy Since 07-May-2019
$7
$5.5 (366.67%)
$7
1 years 5 months 6 days ago
(29-Apr-2025)
0/5 (0%)
$6 (600.00%)
Buy Since 07-May-2019
1 years 5 months 6 days ago
(29-Apr-2025)
0/16 (0%)
$5.29 (309.36%)
Hold Since 24-Apr-2025
$1.05
$-0.45 (-30.00%)
1 years 5 months 11 days ago
(24-Apr-2025)
2/3 (66.67%)
$0.04 (3.96%)
9
Buy Since 23-Jan-2024
$6
$4.5 (300.00%)
1 years 10 months ago
(05-Dec-2024)
0/3 (0%)
$4.49 (297.35%)
What is CHRS (Coherus BioSciences) average time for price targets to be met?
Which analyst most recently updated their price target on CHRS (Coherus BioSciences)?
Which analyst has the most public recommendations on CHRS (Coherus BioSciences)?
Which analyst is the currently most bullish on CHRS (Coherus BioSciences)?
Which analyst is the currently most reserved on CHRS (Coherus BioSciences)?